2023. Anti-tumor necrosis factor α: originators versus biosimilars, comparison in clinical response assessment in a multicenter cohort of patients with inflammatory arthropathies. Reumatismo. 75, 4 (Dec. 2023). DOI:https://doi.org/10.4081/reumatismo.2023.1602.